Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.7K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

557
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
557
Cancer Therapies02:49

Cancer Therapies

9.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K
Cancer Prevention02:59

Cancer Prevention

7.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.5K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.1K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Infertility in Females01:28

Infertility in Females

3.5K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.

JAMA oncology·2026
Same author

Patients' Perception of Follow-Up Care and Personal Health Status of 677 Long-Term Survivors of Gynecological Cancer from the Study "Expression IX-Long-Term Survival with Gynecological Cancer": The International NOGGO, ENGOT and GCIG Survey.

Cancers·2026
Same author

Lenvatinib plus pembrolizumab in participants with advanced or recurrent endometrial cancer: Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

A review of reviews of the prevalence of molecular biomarkers in vulvar cancer and their implications for prognosis refinement and treatment strategies.

Gynecologic oncology·2026
Same author

First-line immunotherapy with or without PARP inhibitors in advanced ovarian cancer: A meta-analysis including bevacizumab use, molecular status, and PD-L1 expression.

Critical reviews in oncology/hematology·2026
Same author

Apparent tissue sodium concentration quantification across reconstruction methods with different partial volume effect reduction - A preliminary study.

Zeitschrift fur medizinische Physik·2026

Related Experiment Video

Updated: Dec 6, 2025

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

12.7K

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.

Irina Tsibulak1, Elisabeth Reiser1, Gerhard Bogner2

  • 1Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|October 9, 2020
PubMed
Summary
This summary is machine-generated.

The COVID-19 lockdown in Austria significantly reduced new gynecological and breast cancer diagnoses. This decline in early cancer detection may negatively impact treatment outcomes, necessitating new strategies for future pandemics.

Keywords:
neoplasms

More Related Videos

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.5K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.5K

Related Experiment Videos

Last Updated: Dec 6, 2025

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

12.7K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.5K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.5K

Area of Science:

  • Oncology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic prompted a nationwide lockdown in Austria starting March 16, 2020.
  • Restrictions on screening and routine checkups aimed to conserve hospital resources and prevent viral spread.
  • This led to a significant reduction in patient referrals to healthcare facilities.

Purpose of the Study:

  • To evaluate the impact of the COVID-19 pandemic on the incidence of newly diagnosed gynecological and breast cancers in Austria.
  • To compare cancer diagnosis rates before and after the pandemic-induced lockdown.

Main Methods:

  • Data from 2077 patients with newly diagnosed gynecological or breast cancer across 18 Austrian centers were analyzed.
  • Patient data from January-May 2019 were compared with data from January-May 2020.
  • Clinical parameters including symptoms, performance status, comorbidities, and referral status were assessed.

Main Results:

  • A slight increase in diagnoses was observed in January-February 2020 (+2% and +35% vs. 2019).
  • Following the lockdown, diagnoses dropped significantly: -24% in March, -49% in April, and -49% in May 2020 compared to 2019.
  • Patients diagnosed during the pandemic were more likely to present with tumor-specific symptoms (two-thirds vs. <50% pre-pandemic) and fewer comorbidities (50% vs. 35% pre-pandemic).

Conclusions:

  • The COVID-19 lockdown in Austria resulted in a substantial decrease in newly diagnosed gynecological and breast cancers.
  • Reduced access to medical services and delayed diagnoses during the pandemic may hinder cancer treatment outcomes.
  • Developing new strategies for early cancer detection is crucial for optimizing cancer care during future pandemics.